5′-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK alpha-2) (AMPK α2β1γ1)

The 5′-AMP-activated protein kinase (AMPK) α2β1γ1 heterotrimer is a vital energy-sensing enzyme complex that maintains cellular metabolic balance. The α2 subunit, encoded by the PRKAA2 gene, provides the catalytic activity and is primarily expressed in skeletal muscle and the heart (UniProt P54646 [1]). This specific heterotrimer is activated by an increase in the cellular AMP:ATP ratio, which occurs during exercise, hypoxia, or nutrient deprivation (Hardie et al., 2012 [2]). Upon activation, it phosphorylates key targets like acetyl-CoA carboxylase to promote fatty acid oxidation and glucose uptake while inhibiting energy-consuming processes (Steinberg & Carling, 2019 [4]). Because of its role in improving insulin sensitivity and lipid metabolism, the α2β1γ1 complex is a major therapeutic target for type 2 diabetes and obesity. Pharmacological activation can be achieved indirectly through metformin or directly via small molecules that target the Allosteric Drug and Metabolite (ADaM) site (Myers et al., 2017 [3]). However, drug development must address potential safety concerns, such as cardiac hypertrophy, which has been observed with chronic systemic activation of certain AMPK isoforms. Current research focuses on developing isoform-selective activators to maximize metabolic benefits while minimizing off-target effects in non-target tissues.

Other names

PRKAA2AMPK alpha 25'-AMP-activated protein kinase subunit alpha-2AMPK2ACACADProtein kinase AMP-activated catalytic subunit alpha 2

The AMPK α2β1γ1 heterotrimer is activated allosterically by the binding of AMP or ADP to the gamma-1 subunit, which induces a conformational change that promotes phosphorylation of the alpha-2 subunit at Thr172 by upstream kinases like LKB1 (Hardie et al., 2012 [2]). Direct pharmacological activators, such as PF-06409577 and A-769662, bind to the Allosteric Drug and Metabolite (ADaM) site located at the interface of the alpha-catalytic and beta-regulatory subunits, stabilizing the active kinase conformation and protecting it from dephosphorylation (Myers et al., 2017 [3]; Steinberg & Carling, 2019 [4]). Once active, the enzyme phosphorylates downstream targets like acetyl-CoA carboxylase (ACC) to inhibit lipid synthesis and stimulate fatty acid oxidation.